Twist Bioscience Corporation - Common Stock (NQ:TWST)

155.67 -11.30 (-6.77%)

Delayed Quote Updated: 2:18 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Twist Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference

November 09, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List

November 02, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021

November 01, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Exome 2.0 for Genomics Research

October 20, 2021

From Twist Bioscience Corporation

Via Business Wire

Week In Review: Hansoh Signs $456 Million Deal For siRNA Products ↗

October 16, 2021

Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to...

Via Talk Markets

Twist Bioscience and the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical Research

October 13, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Appoints Steffen Hellmold as Senior Vice President, Business Development, Data Storage

October 12, 2021

From Twist Bioscience Corporation

Via Business Wire

Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases ↗

October 06, 2021

Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for rare diseases. The...

Via Benzinga

Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

October 06, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Expands Expert Custom Alliance Panel Offering

October 05, 2021

From Twist Bioscience Corporation

Via Business Wire

Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation

September 29, 2021

SOURCE: Illumina

Via 3BL Media

Twist Bioscience Appoints Dennis Cho as Senior Vice President, General Counsel and Chief Ethics and Compliance Officer

September 27, 2021

From Twist Bioscience

Via Business Wire

Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical Studies

September 23, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library Design

September 23, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19

September 14, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics

September 13, 2021

From Twist Bioscience Corporation and Adicet Bio

Via Business Wire

Twist Bioscience, Boehringer Ingelheim Joins Forces For Antibody Research Programs ↗

September 09, 2021

Twist Bioscience Corporation (NASDAQ: TWST) has announced a broad-based research collaboration with Boehringer Ingelheim International GmbH. The collaboration...

Via Benzinga

Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration

September 09, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at Baird 2021 Global Healthcare Conference

September 08, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience, SomaLogic Team Up For Antibodies, Target Discovery ↗

August 18, 2021

Twist Bioscience Corporation (NASDAQ: TWST) and SomaLogic announced a partnership to discover novel therapeutic targets and antibodies. Financial and other...

Via Benzinga

Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit

August 10, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Corporation (TWST) Q3 2021 Earnings Call Transcript ↗

August 06, 2021

TWST earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Twist Bioscience Stock Falls On Wider Q3 Loss, Sales Beat Estimates; Raises FY21 Guidance ↗

August 06, 2021

Twist Bioscience Corporation (NASDAQ: TWST) reported a 65% Y/Y increase in its third-quarter revenues to $35 million, beating the Wall Street estimate of $32.27 million...

Via Benzinga

Topics Earnings

Twist Bioscience: Q3 Earnings Insights ↗

August 06, 2021

Shares of Twist Bioscience (NASDAQ:TWST) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share were down 22.39% year over year to...

Via Benzinga

Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results

August 06, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors

August 06, 2021

From Twist Bioscience Corporation

Via Business Wire

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

Earnings Scheduled For August 6, 2021 ↗

August 06, 2021

Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million....

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery

July 26, 2021

From Twist Bioscience Corporation

Via Business Wire

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.